SEARCH

SEARCH BY CITATION

References

  • Abercrombie E. D. and DeBoer P. (1997) Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism. J. Neurosci. 17, 84988505.
  • Abi-Dargham A., Gil R., Krystal J., Baldwin R., Seibyl J., Bowers M., Van Dyck C. H., Charney D. S., Innis R. B. and Laruelle M. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761767.
  • Abi-Dargham A., Rodenhiser J., Printz D. et al. (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl Acad. Sci. USA 97, 81048109.
  • Abi-Dargham A., Van De Giessen E., Slifstein M., Kegeles L. S. and Laruelle M. (2009) Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol. Psychiatry 65, 10911093.
  • Akil M., Pierri J. N., Whitehead R. E., Edgar C. L., Mohila C., Sampson A. R. and Lewis D. A. (1999) Lamina-specific alterations in the dopamine innervations of the prefrontal cortex in schizophrenic subjects. Am. J. Psychiatry 156, 15801589.
  • Akil M., Edgar C. L., Pierri J. N., Casali S. and Lewis D. A. (2000) Decreased density of tyrosine hydroxylase immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol. Psychiatry 47, 361370.
  • Alexander G. E., DeLong M. R. and Strick P. L. (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 9, 357381.
  • Alexander G. E., Crutcher M. D. and DeLong M. R. (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, ‘prefrontal’ and ‘limbic’ functions. Prog. Brain Res. 85, 119146.
  • Altamura A. C., Bassetti R., Cattaneo E. and Vismara S. (2005) Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J. Biol. Psychiatry. 6(Suppl 2), 2330.
  • American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
  • Andreasen N. C. and Olsen S. (1982) Negative vs. positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry 39, 789794.
  • Arakawa R., Ichimiya T., Ito H. et al. (2009) Increase in thalamic binding of [(11)C]PE2l in patients with schizophrenia: a positron emission tomography study of dopamine transporter. J. Psychiatry. Res. 43, 12191223.
  • Arango C., Breier A., McMahon R., Carpenter W. T. Jr and Buchanan R. W. (2003) The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. Am. J. Psychiatry 160, 14211427.
  • Arango C., Buchanan R. W., Kirkpatrick B. and Carpenter W. T. (2004) The deficit syndrome in schizophrenia: implications for the treatment of negative symptoms. Eur. Psychiatry 19, 2126.
  • Aron A. R. and Poldrack R. A. (2006) Cortical and subcortical contributions to Stop signal response inhibition: a role of the subthalamic nucleus. J. Neurosci. 26, 24242433.
  • Averback P. (1981) Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch. Neurol. 38, 230235.
  • Ballmaier M., Schlagenhauf F., Toga A. W., Gallinat J., Koslowski M., Zoli M., Hojatkashani C., Narr K. L. and Heinz A. (2008) Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr. Res. 106, 140147.
  • Bedard A., Gravel C. and Parent A. (2006) Chemical characterization of newly generated neurons in the striatum of adult primates. Exp. Brain Res. 170, 501512.
  • Beerpoot L. J., Lipska B. K. and Weinberger D. R. (1996) Neurobiology of treatment-resistant schizophrenia: new insights and new models. Eur. Neuropsychopharmacol. 6(Suppl. 2), S27S34.
  • Benarroch E. E. (2008) Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation. Neurology 70, 19911995.
  • Ben-Shachar D. (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J. Neurochem. 83, 12411251.
  • Ben-Shachar D. and Laifenfeld D. (2004) Mitochondria, synaptic plasticity, and schizophrenia. Int. Rev. Neurobiol. 59, 273296.
  • Bentivoglio M. and Morelli M. (2005) The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain, in Handbook of Chemical Neuronatomy (DunnettS. B., BentivoglioM., BjorklundA. and HokfeltT., eds), pp. 1107. Elsevier, Amsterdam.
  • Betarbet R., Turner R., Chockkan V., DeLong M. R., Allers K. A., Walters J., Levey A. I. and Greenamyre J. T. (1997) Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17, 67616768.
  • Bilder R. M., Wu H., Chakos M. H., Bogerts B., Pollack S., Aronowitz J., Ashtari M., Degreef G., Kane J. M. and Lieberman J. A. (1994) Cerebral morphometry and clozapine treatment in schizophrenia. J. Clin. Psychiatry 55, 5356.
  • Bjorklund A. and Dunnett S. B. (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194202.
  • Bogerts B., Hantsch J. and Herzer M. (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, parkinson patients, and schizophrenics. Biol. Psych. 18, 951969.
  • Brandt G. N. and Bonelli R. M. (2008) Structural Neuroimaging of the basal ganglia in schizophrenic patients: a review. Wien. Med. Wochenschr. 158, 8490.
  • Brauer K., Häusser M., Härtig W. and Arendt T. (2000) The core-shell dichotomy of nucleus accumbens in the rhesus monkey as revealed by double-immunofluorescence and morphology of cholinergic interneurons. Brain Res. 858, 151162.
  • Breier A., Su T. P., Saunders R. et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl Acad. Sci. USA 94, 25692574.
  • Buchsbaum M. S. and Hazlett E. A. (1998) Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr. Bull. 24, 343364.
  • Buchsbaum M. S., Potkin S. G., Siegel B. V. Jr, Lohr J., Katz M., Gottschalk L. A., Gulasekaram B., Marshall J. F., Lottenberg S. and Teng C. Y. (1992) Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch. Gen. Psychiatry 49, 966974.
  • Buchsbaum M. S., Christian B. T., Lehrer D. S., Narayanan T. K., Shi B., Mantil J., Kemether E., Oakes T. R. and Mukherjee J. (2006) D2/D3 dopamine receptor binding with [F-18] fallypride in thalamus and cortex of patients with schizophrenia. Schizophr. Res. 85, 232244.
  • Byne W., Hazlett E. A., Buchsbaum M. S. and Kemether E. (2009) The thalamus and schizophrenia: current status. Acta Neuropathol. 117, 347368.
  • Carlsson A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1, 179186.
  • Carlsson A. and Lindqvist M. (1963) Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. (Copenh) 20, 140144.
  • Carpenter M. B. and Peter P. (1972) Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J. Comp. Neurol. 144, 93115.
  • Carpenter M. B., Baton R. R. 3rd, Carleton S. C. and Keller J. T. (1981) Interconnections and organization of pallidal and subthalamic nucleus neurons in the monkey. J. Comp. Neurol. 197, 579603.
  • Carpenter W. T. Jr, Heinrichs D. W. and Wagman A. M. (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psych. 145, 578583.
  • Charara A., Smith Y. and Parent A. (1996) Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J. Comp. Neurol. 364, 254266.
  • Civelli O., Bunzow J. R., Grandy D. K., Zhou Q. Y. and Van Tol H. H. (1991) Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207, 277286.
  • Clinton S. M. and Meador-Woodruff J. H. (2004) Thalamic dysfunction in schizophrenia: neurochemical, neuropathololical, and in vivo imaging abnormalities. Schizophr. Res. 69, 237253.
  • Clinton S. M., Ibrahim H. M., Frey K. A., Davis K. L., Haroutunian V. and Meador-Woodruff J. H. (2005) Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophillin. Am. J. Psychiatry 162, 18591871.
  • Cobb W. S. and Abercrombie E. D. (2003) Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent. Neuroscience 119, 777786.
  • Cohen B. M., Wan W., Froimowitz M. P., Ennulat D. J., Cherkerzian S. and Konieczna H. (1998) Activation of midline thalamic nuclei by antipsychotic drugs. Psychopharmacology (Berl) 135, 3743.
  • Conley R. R. and Kelly D. L. (2000) Pharmacologic Treatment of Schizophrenia, 1st edn. Professional Communications Inc., Cado, OK, USA.
  • Conley R. R. and Kelly D. L. (2001) Management of treatment resistance in schizophrenia. Biol. Psychiatry 50, 898911.
  • Coppens H. J., Slooff C. J., Paans A. M., Wiegman T., Vaalburg W. and Korf J. (1991) High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients. Biol. Psychiatry 29, 629634.
  • Cossette M., Lecomte F. and Parent A. (2005) Morphology and distribution of dopaminergic neurons intrinsic to the human striatum. J. Chem. Neuroanat. 29, 111.
  • Cote P. Y., Sadikot A. F. and Parent A. (1991) Complementary distribution of calbindin D-28K and parvalbumin in the basal forebrain and midbrain of the squirrel monkey. Eur. J. Neurosci. 12, 13161329.
  • Cousins D. A., Butts K. and Young A. H. (2009) The role of dopamine in bipolar disorder. Bipolar Disord., 11, 787806.
  • Coyle J. T. (2006) Glutamate and schizophrenic: beyond the dopamine hypothesis. Cell Mol. Neurobiol. 26, 365384.
  • Cragg S. J., Baufreton J., Xue Y., Bolam J. P. and Bevan M. D. (2004) Synaptic release of dopamine in the subthalamic nucleus. Eur. J. Neurosci. 20, 17881802.
  • Creese I., Burt D. R. and Snyder S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481483.
  • Dahlstrom A. and Fuxe K. (1964) Evidence for the existence of monoamine-containing neurons in the central system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 232, 155.
  • D’Ardenne K., McClure S. M., Nystrom L. E. and Cohen J. D. (2008) BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 319, 12641267.
  • Davies N., Russell A., Jones P. and Murray R. M. (1998) Which characteristics of schizophrenia predate psychosis? J. Psychiatr. Res. 32, 121131.
  • Davis K. L., Kahn R. S., Ko G. and Davidson M. (1991) Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 14741486.
  • De Almeida J., Palacios J. M. and Mengod G. (2008) Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatement. Prog. Brain Res. 172, 101115.
  • De Keyser J., Claeys A., De Backer J. P., Ebinger G., Roels F. and Vauquelin G. (1988) Autoradiographic localization of D1 and D2 dopamine receptors in the human brain. Neurosci. Lett. 91, 142147.
  • De la Fuente-Sandoval C., Favila R., Alvarado P., León-Ortiz P., Díaz-Galvis L., Amezcua C., García-Muñoz E. and Graff-Guerrero A. (2009) Glutamate increase in the associative striatum in schizophrenia: a longitudinal magnetic resonance spectroscopy preliminary study. Gac. Med. Mex. 145, 109113.
  • Delay J., Deniker P. and Harl J. M. (1952) Therapeutic use in psychiatry of phenothiazine of central elective action (4560 RP). Ann. Med. Psychol. (Paris) 110, 112117.
  • DeLisi L. E., Shaw S. H., Crow T. J. et al. (2002) A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry 159, 803812.
  • Deniau J. M. and Chevalier G. (1985) Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res. 334, 227233.
  • Deniau J. M., Mailly P., Maurice N. and Charpier S. (2007) The pars reticulata of the substantia nigra: a window to basal ganglia output. Prog. Brain Res. 160, 151172.
  • Descarries L., Watkins K. C., Garcia S., Bosler O. and Doucet G. (1996) Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol. 375, 167186.
  • Dreher J.-C., Kohon P., Kolachana B., Weinberger D. R. and Berman K. F. (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl Acad. Sci. USA 106, 617622.
  • Dunlop B. W. and Nemeroff C. B. (2007) The role of dopamine in the pathophysiology of depression. Arch. of Gen. Psych. 64, 32337.
  • Fatemi S. H. and Folsom T. D. (2009) The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr. Bull. 35, 528548.
  • Fattal O., Budur K., Vaughan A. J. and Franco K. (2006) Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47, 17.
  • Francois C., Yelnik J., Tande D., Agid Y. and Hirsch E. C. (1999) Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum. J. Comp. Neurol. 414, 334347.
  • Frankle W. G., Laruelle M. and Haber S. N. (2006) Prefrontal cortical projections to the midbrain in primates: evidence for a sparse connection. Neuropsychopharmacology 31, 16271636.
  • Garcia-Cabezas M. A., Rico B., Sanchez-Gonzalez M. A. and Cavada C. (2007) Distribution of the dopamine innervation in the macaque and human thalamus. Neuroimage 34, 965984.
  • Garris P. A., Ciolkowski E. L., Pastore P. and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 60846093.
  • Gerfen C. R. (1984) The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311, 461464.
  • Gerfen C. R. (1989) The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 246, 385388.
  • Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15, 285320.
  • Gerfen C. R. (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23, S64S70.
  • Gerfen C. R., Herkenham M. and Thibault J. (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7, 39153934.
  • Gerfen C. R., McGinty J. F. and Young W. S. 3rd. (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11, 10161031.
  • Goldman-Rakic P. S. (1999) The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 46, 650661.
  • Goldsmith S. K., Shapiro R. M. and Joyce J. N. (1997) Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study. Arch. Gen. Psychiatry 54, 649658.
  • Graveland G. A. and DiFiglia M. (1985) The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res. 327, 307311.
  • Graybiel A. M. (1984) Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 13, 11571187.
  • Graybiel A. M. and Hickey T. I. (1982) Chemospecificity of ontogenetic units in the striatum: demonstration by combining [3H]thymidine neuronography and histochemical staining. Proc. Natl Acad. Sci. USA 79, 198202.
  • Graybiel A. M. and Ragsdale C. W. Jr (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acethycholinesterase staining. Proc. Natl Acad. Sci. USA 75, 57235726.
  • Graybiel A. M., Hirsch E. C. and Agid Y. A. (1987) Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc. Natl. Acad. Sci. USA 84, 303307.
  • Graybiel A. M., Flaherty A. W. and Gimenez-Amaya J. M. (1991) Striosomes and matrisomes, in The Basal Ganglia III (BernadiG., ed.), pp. 312. Plenum Press, New York.
  • Groenewegen H. J., Wright C. I., Beijer A. V. and Voorn P. (1999) Convergence and segregation of ventral striatal inputs and outputs. Ann. N Y Acad. Sci. 877, 4963.
  • Haber S. N. (2003) The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 26, 317330.
  • Haber S. N. and McFarland N. R. (1999) The concept of the ventral striatum in nonhuman primates. Ann. N Y Acad. Sci. 877, 3348.
  • Haber S. N., Fudge J. L. and McFarland N. R. (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20, 23692382.
  • Haber S. N., Kim K.-S., Mailly P. and Calzavara R. (2006) Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 26, 83688376.
  • Halliday G. (2004) Substantia nigra and locus coeruleus, in The Human Nervous System (PaxinosG. and MayJ. K., eds), pp. 449463. Elsevier, Amsterdam.
  • Harrison P. J. (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122, 593624.
  • Harrison P. J. and Weinberger D. R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 4068.
  • Hedreen J. C. (1999) Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J. Comp. Neurol. 409, 400410.
  • Hedreen J. C. and DeLong M. R. (1991) Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J. Comp. Neurol. 304, 569595.
  • Heimer L. (1978) The olfactory cortex and the ventral striatum, in Limbic Mechanisms: The Continuing Evolution of the Limbic System Concept (LivingstonK. E. and HornikiewiczO., eds), pp. 95187. Plenum, New York.
  • Hietala J., Syvälahti E., Vuorio K. et al. (1995) Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346, 11301131.
  • Hietala J., Syvälahti E., Wilkman H. et al. (1999) Depressive symptoms and presynaptic dopamine function in neuroleptic-naïve schizophrenia. Schizophr. Res. 35, 4150.
  • Hirvonen J., Van Erp T. G., Huttunen J. et al. (2006) Brain dopamine D1 receptors in twins discordant for schizophrenia. Am. J. Psychiatry 163, 17471753.
  • Holcomb H. H., Cascella N. G., Thaker G. K., Medoff D. R., Dannals R. F. and Tamminga C. A. (1996) Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am. J. Psychiatry 153, 4149.
  • Holt D. J., Graybiel A. M. and Saper C. B. (1997) Neurochemical architecture of the human striatum. J. Comp. Neurol. 384, 125.
  • Holt D. J., Herman M. M., Hyde T. M., Kleinman J. E., Sinton C. M., German D. C., Hersh L. B., Graybiel A. M. and Saper C. B. (1999) Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience 94, 2131.
  • Hong S. and Hikosaka O. (2008) The globus pallidus sends reward-related signals to the lateral habenula. Neuron 60, 720729.
  • Howes O. D. and Kapur S. (2009) The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr. Bull. 35, 549562.
  • Huot P. and Parent A. (2007) Dopaminergic neurons intrinsic to the striatum. J. Neurochem. 101, 14411447.
  • Huttunen J., Heinimaa M., Svirskis T. et al. (2008) Striatal dopamine synthesis in first degree relatives of patients with schizophrenia. Biol. Psych. 63, 114117.
  • Hwang J., Lyoo I. K., Dager S. R., Friedman S. D., Oh J. S., Lee J. Y., Kim S. J., Dunner D. L. and Renshaw P. F. (2006) Basal ganglia shape alterations in bipolar disorder. Am. J. Psychiatry 163, 276285.
  • Iversen S. D. and Iversen L. L. (2007) Dopamine: 50 years in perspective. Trends Neurosci. 30, 188193.
  • Jensen J., Willeit M., Zipursky R. B., Savina I., Smith A. J., Menon M., Crawley A. P. and Kapur S. (2008) The formation of abnormal associations in schizophrenia: neural and behavioral evidence. Neuropsychopharmacology 33, 473479.
  • Joyce J. N. and Meador-Woodruff J. H. (1997) Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology 16, 375384.
  • Joel D. and Weiner I. (2000) The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96, 451474.
  • Juckel G., Schlagenhauf F., Koslowski M. et al. (2006) Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology 187, 222228.
  • Kane J. M., Honigfeld G., Singer J. and Meltzer H. (1988) Clozapine in treatment-resistant schizophrenics. Psychopharmacol. Bull. 24, 6267.
  • Kelley J. J., Gao X. M., Tamminga C. A. and Roberts R. C. (1997) The effect of chronic haloperidol treatment on dendritic spines in the rat striatum. Exp. Neurol. 146, 471478.
  • Kessler R. M., Woodward N. D., Riccardi P., Li R., Ansari M. S., Anderson S., Dawant B., Zald D. and Meltzer H. Y. (2009) Dopamine D (2) receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol. Psychiatry 65, 10241031.
  • Kim J. S., Kornhuber H. H., Schmid-Burgk W. and Holzmuller B. (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20, 379382.
  • Kirkpatrick B., Buchanan R. W., Ross D. E. and Carpenter W. T. Jr (2001) A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 58, 165171.
  • Kita H. (2007) Globus pallidus external segment. Prog. Brain Res. 160, 111133.
  • Kleinman J. E., Hong J., Iadarola M., Govoni S. and Gillin C. J. (1985) Neuropeptides in human brain – postmortem studies. Biol. Psychiatry 9, 9195.
  • Knutson B. and Cooper J. C. (2005) Functional magnetic resonance imaging of reward prediction. Curr. Opin. Neurol. 18, 411417.
  • Knutson B., Adams C. M., Fong G. W. and Hommer D. (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 21, RC159.
  • Kolomeets N. S. and Uranova N. A. (1997) Synaptic contacts in schizophrenia: study with immunocytochemical identification of dopaminergic neurons. Zh. Nevrol. Psikhiatri. Im. S. S. Korsakova 97, 3943.
  • Kolomeets N. S. and Uranova N. A. (1999) Synaptic contacts in schizophrenia: study with immunocytochemical identification of dopaminergic neurons. Neurosci. Behav. Physiol. 29, 217221.
  • Van Der Kooy D. and Fishell G. (1987) Neuronal birthdate underlies the development of striatal compartments. Brain Res. 401, 155161.
  • Korpi E. R., Kleinman J. E., Goodman S. I., Phillips I., DeLisi L. E., Linnoila M. and Wyatt R. J. (1986) Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. Arch. Gen. Psychiatry 43, 594600.
  • Kreczmanski P., Heinsen H., Mantua V. et al. (2007) Volume, neuronal density and total neuron number in five subcortical regions in schizophrenia. Brain 130, 678692.
  • Kung L. and Roberts R. C. (1999) Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 31, 6775.
  • Kung L., Conley R., Chute D. J., Smialek J. and Roberts R. C. (1998) Synaptic changes in the striatum of schizophrenic cases: a controlled postmortem ultrastructural study. Synapse 28, 125139.
  • Lahti R. A., Roberts R. C. and Tamminga C. A. (1995) D2-family receptor distribution in human postmortem tissue: an autoradiographic study. NeuroReport 6, 25052512.
  • Lahti R. A., Cochrane E. V., Roberts R. C., Conley R. R. and Tamminga C. A. (1998) [3H] neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study. J. Neural Transm. 105, 507516.
  • Langer L. F. and Graybiel A. M. (1989) Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 498, 344350.
  • Laruelle M., Abi-Dargham A., Gil R., Kegeles L. and Innis R. (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46, 5672.
  • Lavoie B. and Parent A. (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J. Comp. Neurol. 299, 116.
  • Lavoie B. and Parent A. (1994) Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J. Comp. Neurol. 344, 232241.
  • Lee K. J., Lee J. S., Correl C. U., Wee H., Yoo S. Y., Jeong J. M., Lee D. S., Lee S. I. and Kwong J. S. (2008) Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia. Acta Psychiatr. Scand. 118, 200208.
  • Lévesque J. C. and Parent A. (2005) GABAergic interneurons in human subthalamic nucleus. Mov. Disorders 20, 574584.
  • Lewis D. A. (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Brain Res. Rev. 31, 270276.
  • Lewis D. A. and Sweet R. A. (2009) Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J. Clin. Invest. 119, 706716.
  • Lewis D. A., Hashimoto T. and Morris H. M. (2008) Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox. Res. 14, 237248.
  • Liddle P. F. (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br. J. Psychiatry 151, 145151.
  • Lynd-Balta E. and Haber S. N. (1994) Primate striatonigral projections: a comparison of the sensorimotor-related striatum and the ventral striatum. J. Comp. Neurol. 345, 562578.
  • Lyon G. J., Abi-Dargham A., Moore H., Lieberman J. A., Javitch J. A. and Sulzer D. (2009) Presynaptic regulation of dopamine transmission in schizophrnenia. Schizophr. Bull., in press. doi:10.1093/schbul/sbp010
  • Mai J. K., Berger K. and Sofroniew M. V. (1993) Morphometric evaluation of neurophysin-immunoreactivity in human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. J. Hirnforsch. 34, 133154.
  • Mamah D., Wang L., Barch D., De Erausquin G. A., Gado M. and Csernansky J. G. (2007) Structural analysis of the basal ganglia in schizophrenia. Schizophr. Res. 89, 5971.
  • Marani E., Heida T., Lakke E. A. and Usunoff K. G. (2008) The subthalamic nucleus. Part 1: development, cytology, topography and connections. Adv. Anat. Embryol. Cell Biol. 198, 1113.
  • McFarland N. R. and Haber S. N. (2002) Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J. Neurosci. 22, 81178132.
  • Melchitzky D. S., Erickson S. L. and Lewis D. A. (2006) Dopamine innervation of the monkey mediodorsal thalamus: location of projection neurons and ultrastructural characteristics of axon terminals. Neuroscience 143, 10211030.
  • Meltzer H. Y. (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 99(Suppl), S18S27.
  • Meredith G. E., Baldo B. A., Andrezjewski M. E. and Kelley A. E. (2008) The structural basis for mapping behavior onto the ventral striatum and its subdivisions. Brain Struct. Funct. 213, 1727.
  • Mitelman S. A., Shihabuddin L., Brickman A. M., Hazlett E. A. and Buchsbaum M. S. (2005) Volume of the cingulate and outcome in schizophrenia. Schizophr. Res. 72, 91108.
  • Mueller H. T., Haroutunian V., Davis K. L. and Meador-Woodruff J. H. (2004) Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Brain Res. Mol. Brain Res. 121, 6069.
  • Murray G. K., Corlett P. R., Clark L., Pessiglione M., Blackwell A. D., Honey G., Jones P. B., Bullmore E. T., Robbins T. W. and Fletcher P. C. (2008) Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol. Psychiatry 239, 267276.
  • Nagaska G. (1925) Zur Pathologie der extrapyramidalen Zentren bei Schizophrenie. Arb. Neur. Inst. Wien 27, 363396.
  • Nambu A. (2004) A new dynamic model of the cortico-basal ganglia loop. Prog. Brain Res. 143, 461466.
  • Nambu A. (2007) Globus pallidus internal segment. Prog. Brain Res. 160, 135150.
  • Nambu A., Tokuno H. and Takada M. (2002) Functional significance of the cortico-subthalamo-pallidal ‘hyperdirect’ pathway. Neurosci. Res. 43, 111117.
  • Nauta H. J. and Cole M. (1978) Efferent projections of the subthalamic nucleus: an autoradiographic study in monkey and cat. J. Comp. Neurol. 180, 116.
  • Nieuwenhuys R., Voogd J. and Van Huijzen C. (2008) Telencephalon: basal ganglia, in The Human Central Nervous System (NieuwenhuysR., VoogdJ. and Van HuijzenC., eds), pp. 427489. Springer, Berlin.
  • Nirenberg M. J., Vaughan R. A., Uhl G. R., Kuhar M. J. and Pickel V. M. (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16, 436447.
  • Nozaki S., Kato M., Takano H. et al. (2009) Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. Schizophr. Res. 108, 7884.
  • Nudmamud-Thanoi S., Piyabhan P., Harte M. K., Cahir M. and Reynolds G. P. (2007) Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J. Neural Transm. Suppl. 72, 281285.
  • Oke A. F. and Adams R. N. (1987) Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophr. Bull. 13, 589604.
  • Owen R., Owen F., Poulter M. and Crow T. J. (1984) Dopamine D2 receptors in substantia nigra in schizophrenia. Brain Res. 299, 152154.
  • Palacios J. M., Camps M., Cortes R. and Probst A. (1988) Mapping dopamine receptors in the human brain. J. Neural Transm. Suppl. 27, 227235.
  • Paradiso S., Andreasen N. C., Crespo-Facorro D., O’Leary D. S., Watkins G. L., Boles Ponto L. L. and Hichwa R. D. (2003) Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am. J. Psychiatry 160, 17751783.
  • Parent A. and Hazrati L. N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Brain Res. Rev. 20, 91127.
  • Parent M. and Parent A. (2007) The microcircuitry of the primate subthalamic nucleus. Parkinsonism Relat. Disord. Suppl. 3, S292S295.
  • Parent A. and Smith Y. (1987) Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res. 436, 296310.
  • Parent A., Fortin M., Côté P. Y. and Cicchetti F. (1996) Calcium-binding proteins in primate basal ganglia. Neurosci. Res. 25, 309334.
  • Parent A., Sato F., Wu Y., Gauthier J., Levesque M. and Parent M. (2000) Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci. 23, S20S27.
  • Penny G. R., Wilson C. J. and Kitai S. T. (1988) Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J. Comp. Neurol. 269, 275289.
  • Perez-Costas E., Melendez-Ferro M., Gao X. M., Conley R. and Roberts R. C. (2007) Decreased expression of tyrosine hydroxylase in the substantia nigra of schizophrenia brains. Schizophr. Bull. 33, 266.
  • Perez-Costas E., Melendez-Ferro M., Rice M. W. and Roberts R. C. (2009) Dopamine Pathology in Schizophrenia: Analysis of Total and Active Form of Tyrosine Hydroxylase in the Substantia Nigra. Program No. 340.2/N23. 2009 Neuroscience Meeting Planner. Society for Neuroscience, Chicago, IL. Online.
  • Pieczenik S. R. and Neustadt J. (2007) Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. 83, 8492.
  • Porritt M. J., Batchelor P. E., Hughes A. J., Kalnins R., Donnan G. A. and Howells D. W. (2000) New dopaminergic neurons in Parkinson’s disease striatum. Lancet 356, 4445.
  • Powers R. E. (1999) The neuropathology of schizophrenia. J. Neuropathol. Exp. Neurol. 58, 679690.
  • Prensa L. and Parent A. (2001) The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J. Neurosci. 21, 72477260.
  • Prensa L., Gimenez-Amaya J. M. and Parent A. (1999a) Chemical heterogeneity of the striosomal compartment in the human striatum. J. Comp. Neurol. 413, 603618.
  • Prensa L., Parent A. and Gimenez-Amaya J. M. (1999b) Compartmentalized organization of human corpus striatum. Rev. Neurol. 28, 512519.
  • Prensa L., Cossette M. and Parent A. (2000) Dopaminergic innervation of human basal ganglia. J. Chem. Neuroanat. 20, 207213.
  • Prince J. A., Blennow K., Gottfries C. G., Karlsson I. and Oreland L. (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21, 372379.
  • Pulver A. E. (2000) Search for schizophrenia susceptibility genes. Biol. Psychiatry 47, 221230.
  • Pulver A. E., Mulle J., Nestadt G. et al. (2000) Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol. Psychiatry 5, 650653.
  • Rajarethinam R., Upadhyaya A., Tsou P., Upadhyaya M. and Keshavan M. S. (2007) Caudate volume in offspring of patients with schizophrenia. Br. J. Psychiatry 191, 258259.
  • Raju D. V., Shah D. J., Wright T. M., Hall R. A. and Smith Y. (2006) Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J. Comp. Neurol. 499, 231243.
  • Remington G. (2008) Alterations of dopamine and serotonin transmission in schizophrenia. Prog. Brain Res. 172, 117140.
  • Roberts D. A., Balderson D., Pickering-Brown S. M., Deakin J. F. and Owen F. (1994) The abundance of mRNA for dopamine D2 receptor isoforms in brain tissue from controls and schizophrenics. Brain Res. Mol. Brain Res. 25, 173175.
  • Roberts R. C. and Knickman J. K. (2002) The ultrastructural organization of the patch matrix compartments in the human striatum. J. Comp. Neurol. 452, 128138.
  • Roberts R. C., Conley R. R., Kung L., Peretti F. J. and Chute D. J. (1996) Reduced striatal spine size in schizophrenia: a postmortem ultrastructural study. NeuroReport 7, 12141218.
  • Roberts R. C., Roche J. K. and Conley R. R. (2005a) Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis. Synapse 56, 185197.
  • Roberts R. C., Roche J. K. and Conley R. R. (2005b) Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum. Neurobiol. Dis. 20, 324335.
  • Roberts R. C., Roche J. K. and Conley R. R. (2008) Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia. Synapse 62, 616627.
  • Roberts R. C., Roche J. K., Conley R. R. and Lahti A. C. (2009) Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response. Synapse 63, 520530.
  • Rolls E. T., Grabenhorst F. and Franco L. (2009) Prediction of subjective affective state from brain activations. J. Neurophysiol. 101, 12941308.
  • Sadikot A. F., Parent A., Smith Y. and Bolam J. P. (1992) Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity. J. Comp. Neurol. 320, 228242.
  • Sanchez-Gonzalez M. A., Garcia-Cabezas M. A., Rico B. and Cavada C. (2005) The primate thalamus is a key target for brain dopamine. J. Neurosci. 25, 60766083.
  • Sato F., Lavallee P., Levesque M. and Parent A. (2000a) Single-axon tracing study of neurons of the external segment of the globus pallidus in primate. J. Comp. Neurol. 417, 1731.
  • Sato F., Parent M., Levesque M. and Parent A. (2000b) Axonal branching pattern of neurons of the subthalamic nucleus in primates. J. Comp. Neurol. 424, 142152.
  • Schlagenhauf F., Sterzer P., Schmack K., Ballmaier M., Rapp M., Wrase J., Juckel G., Gallinat J. and Heinz A. (2009) Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol. Psychiatry 65, 10321039.
  • Schultz W. (1998) Predictive reward signal of dopamine neurons. J. Neurophysiol. 80, 127.
  • Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36, 241263.
  • Seeman P. and Kapur S. (2000) Schizophrenia: more dopamine, more D2 receptors. Proc. Natl Acad. Sci. USA 97, 76737675.
  • Seeman P., Lee T., Chau-Wong M. and Wong K. (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261, 717719.
  • Selemon L. D. and Goldman-Rakic P. S. (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45, 1725.
  • Sesack S. R., Aoki C. and Pickel V. M. (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88106.
  • Sheitman B. B. and Lieberman J. A. (1998) The natural history and pathophysiology of treatment resistant schizophrenia. J. Psychiatr. Res. 32, 143150.
  • Shink E., Bevan M. D., Bolam J. P. and Smith Y. (1996) The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73, 335357.
  • Simpson M. D., Slater P., Royston M. C. and Deakin J. F. (1992) Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Psychiatry Res. 42, 273282.
  • Smith Y. and Kieval J. Z. (2000) Anatomy of the dopamine system in the basal ganglia. TINS 23, S28S33.
  • Smith Y. and Parent A. (1986) Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri Sciureus). Neuroscience 18, 347371.
  • Smith Y. and Villalba R. (2008) Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov. Disord. 23, S534S547.
  • Smith Y., Hazrati L. N. and Parent A. (1990) Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J. Comp. Neurol. 294, 306323.
  • Smith Y., Bennett B. D., Bolam J. P., Parent A. and Sadikot A. F. (1994) Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J. Comp. Neurol. 344, 119.
  • Smith Y., Bevan M. D., Shink E. and Bolam J. P. (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86, 353387.
  • Smith Y., Raju D. V., Pare J. F. and Sidibe M. (2004) The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci. 27, 520527.
  • Staal W. G., Hulshoff Pol H. E., Schnack H. G., Van Haren N. E., Seifert N. and Kahn R. S. (2001) Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am. J. Psychiatry 158, 11401142.
  • Stern R. G., Kahn R. S. and Davidson M. (1993) Predictors of response to neuroleptic treatment in schizophrenia. Psychiatr. Clin. North Am. 16, 313338.
  • Suhara T., Okubo Y., Yasuno F. et al. (2002) Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch. Gen. Psychiatry 59, 2530.
  • Takahashi H., Higuchi M. and Suhara T. (2006) The role of extrastriatal dopamine D2 receptors in schizophrenia. Biol. Psychiatry 59, 919928.
  • Tallerico T., Novak G., Liu I. S., Ulpian C. and Seeman P. (2001) Schizophrenia: elevated mRNA for dopamine D2 (Longer) receptors in frontal cortex. Mol. Brain Res. 87, 160165.
  • Taylor S. F., Liberzon I., Decker L. R. and Koeppe R. A. (2002) A functional anatomic study of emotion in schizophrenia. Schizophr. Res. 58, 159172.
  • Taylor S. F., Phan K. L., Britton J. C. and Liberzon I. (2005) Neural response to emotional salience in schizophrenia. Neuropsychopharmacology 30, 984995.
  • Tepper J. M. and Bolam J. P. (2004) Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 14, 685692.
  • Tepper J. M. and Lee C. R. (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog. Brain Res. 160, 189208.
  • Tepper J. M., Abercrombie E. D. and Bolam J. P. (2007) Basal ganglia macrocircuits. Prog. Brain Res. 160, 17.
  • Toru M., Watanabe S., Shibuya H. et al. (1988) Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr. Scand. 78, 121137.
  • Uranova N. A. and Levite O. I. (1987) Ultrastructure of the substantia nigra in schizophrenia. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 87, 10171024.
  • Uranova N. A., Casanova M. F., DeVaughn N. M., Orlovskaya D. D. and Denisov D. V. (1996) Ultrastructural alterations of synaptic contacts and astrocytes in postmortem caudate nucleus of schizophrenic patients. Schizophr. Res. 22, 8183.
  • Uranova N., Orlovskaya D., Vikhreva O., Zimina I., Kolomeets N., Vostrikov V. and Rachmanova V. (2001) Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55, 597610.
  • Uranova N. A., Vostrikov V. M., Vikhreva O. V., Zimina I. S., Kolomeets N. S. and Orlovskaya D. D. (2007) The role of oligodendrocyte pathology in schizophrenia. Int. J. Neuropsychopharmacol. 10, 537545.
  • Walker R. H., Arbuthnott G. W., Baughman R. W. and Graybiel A. M. (1993) Dendritic domains of medium spiny neurons in the primate striatum: relationships to striosomal borders. J. Comp. Neurol. 337, 614628.
  • Walker E. F., Diforio D. and Baum K. (1999) Developmental neuropathology and the precursors of schizophrenia. Acta Psychiatr. Scand. Suppl. 395, 1219.
  • Waltz J. A., Schweitzer J. B., Gold J. M., Kurup P. K., Ross T. J., Salmeron B. J., Rose E. J., McClure S. M. and Stein E. A. (2009) Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 34, 15671577.
  • Wanat M. J., WIlluhn I., Clark J. J. and Phillips P. E. (2009) Phasic dopamine release in appetitive behaviors and drug addiction. Curr. Drug Abuse Rev. 2, 195213.
  • White N. M. and Hiroi N. (1998) Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl Acad. Sci. USA 95, 64866491.
  • Wichmann T. and DeLong M. R. (1996) Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6, 751758.
  • Wilson C. J. (2004) Basal ganglia, in The Synaptic Organization of the Brain (ShepherdG. N., ed.), pp. 361413. Oxford University Press, Oxford.
  • Winterer G. and Weinberger D. R. (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27, 683690.
  • Wong D. F., Wagner H. N. Jr, Tune L. E., Dannals R. F., Pearlson G. D., Links J. M., Tamminga C. A., Broussolle E. P., Ravert H. T. and Wilson A. A. (1986) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234, 15581563.
  • Yung K. K., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J. and Levey A. I. (1995) Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65, 709730.
  • Yung K. K., Smith A. D., Levey A. I. and Bolam J. P. (1996) Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur. J. Neurosci. 8, 861869.
  • Zhou F. W., Jin Y., Matta S. G., Xu M. and Zhou F. M. (2009) An ultra-short dopamine pathway regulates basal ganglia output. J. Neurosci. 29, 1042510435.